From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves new treatment for metastatic HER2 breast cancer

from Medscape

The Food and Drug Administration recently approved ado-trastuzumab emtansine, also known as T-DM1, for the treatment of patients with HER2-positive metastatic breast cancer. T-DM1 is indicated for patients who were previously treated with the anti-HER2 therapy trastuzumab and a taxane chemotherapy. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063